Should You Be Worried About Bioventus Inc.'s (NASDAQ:BVS) 1.3% Return On Equity? [Yahoo! Finance]
Bioventus Inc. - Class A (BVS)
Company Research
Source: Yahoo! Finance
This article is for those who would like to learn about Return On Equity (ROE). By way of learning-by-doing, we'll look at ROE to gain a better understanding of Bioventus Inc. ( NASDAQ:BVS Return on Equity or ROE is a test of how effectively a company is growing its value and managing investors' money. Put another way, it reveals the company's success at turning shareholder investments into profits. Shop Top Mortgage Rates Your Path to Homeownership Learn More A quicker path to financial freedom Learn More Personalized rates in minutes Learn More Powered by Money.com - Yahoo may earn commission from the links above. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. How To Calculate Return On Equity? ROE can be calculated by using the formula: Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity So, based on the above formula, the ROE for Bioventus is: 1.3% = US$2.7
Show less
Read more
Impact Snapshot
Event Time:
BVS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BVS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BVS alerts
High impacting Bioventus Inc. - Class A news events
Weekly update
A roundup of the hottest topics
BVS
News
- Bioventus: A New Start [Seeking Alpha]Seeking Alpha
- Bioventus to Present at the Piper Sandler 37th Annual Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- Bioventus to Present at the Piper Sandler 37th Annual Healthcare ConferenceGlobeNewswire
- Bioventus (NASDAQ:BVS) had its "sell (d+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Bioventus reiterates 2025 guidance with 6%–8% organic growth target as PNS and PRP launches gain traction [Seeking Alpha]Seeking Alpha
BVS
Earnings
- 8/6/25 - Miss
BVS
Sec Filings
- 12/4/25 - Form 144
- 11/25/25 - Form 3
- 11/17/25 - Form 8-K
- BVS's page on the SEC website